Home/Filings/4/0001192482-20-000745
4//SEC Filing

Celano Michael 4

Accession 0001192482-20-000745

CIK 0001374690other

Filed

Sep 29, 8:00 PM ET

Accepted

Sep 30, 2:05 PM ET

Size

5.6 KB

Accession

0001192482-20-000745

Insider Transaction Report

Form 4
Period: 2020-09-29
Celano Michael
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2020-09-29+84,10084,100 total
    Exercise: $11.90Exp: 2030-07-16Common Stock (84,100 underlying)
Footnotes (1)
  • [F1]The Option was granted on July 16, 2020 subject to stockholder approval, which was obtained at the Company's special meeting of stockholders on September 29, 2020. The Option vests 25% on July 16, 2021, with the remaining 75% vesting in equal monthly installments over 36 months, subject to the Reporting Person's continued service with the Issuer through each applicable vesting date.

Issuer

Larimar Therapeutics, Inc.

CIK 0001374690

Entity typeother

Related Parties

1
  • filerCIK 0001377582

Filing Metadata

Form type
4
Filed
Sep 29, 8:00 PM ET
Accepted
Sep 30, 2:05 PM ET
Size
5.6 KB